These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34576312)

  • 21. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
    Yew KS; Kamps-Schmitt KA; Borge R
    Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Up-to-date classification and multidisciplinary symptoms of Ehlers-Danlos syndromes].
    Ralovich FV; Kiss N; Horváth K; Kárpáti S; Medvecz M
    Orv Hetil; 2019 Apr; 160(16):603-612. PubMed ID: 30983397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ehlers-Danlos syndromes: importance of defining the type.
    van Dijk FS; Ghali N; Chandratheva A
    Pract Neurol; 2024 Mar; 24(2):90-97. PubMed ID: 38160052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ehlers-Danlos syndrome: Role of the dentist].
    Melou C; Taillard N; Chauvel-Lebret D
    Orthod Fr; 2021 Sep; 92(3):367-375. PubMed ID: 34583919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.
    Colombi M; Dordoni C; Chiarelli N; Ritelli M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):6-22. PubMed ID: 25821090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical presentation of Ehlers-Danlos syndrome.
    Lawrence EJ
    Adv Neonatal Care; 2005 Dec; 5(6):301-14. PubMed ID: 16338669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classic Ehlers-Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1.
    Chiu WC; Chen SH; Lo MC; Kuo YT
    BMC Pediatr; 2020 Oct; 20(1):495. PubMed ID: 33109150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Many Facets of Hypermobile Ehlers-Danlos Syndrome.
    Riley B
    J Am Osteopath Assoc; 2020 Jan; 120(1):30-32. PubMed ID: 31904772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ehlers-Danlos syndromes].
    Germain DP
    Ann Dermatol Venereol; 2017 Dec; 144(12):744-758. PubMed ID: 29032848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder.
    Venable E; Knight DRT; Thoreson EK; Baudhuin LM
    Am J Med Genet C Semin Med Genet; 2023 Jun; 193(2):147-159. PubMed ID: 36896471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electron microscopy in the diagnosis of Ehlers-Danlos syndromes: correlation with clinical and genetic investigations.
    Angwin C; Ghali N; Baker D; Brady AF; Pope FM; Vandersteen A; Wagner B; Ferguson DJP; van Dijk FS
    Br J Dermatol; 2020 Mar; 182(3):698-707. PubMed ID: 31141158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermobility, the Ehlers-Danlos syndromes and chronic pain.
    Syx D; De Wandele I; Rombaut L; Malfait F
    Clin Exp Rheumatol; 2017; 35 Suppl 107(5):116-122. PubMed ID: 28967365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporomandibular disorders among Ehlers-Danlos syndromes: a narrative review.
    Oelerich O; Daume L; Yekkalam N; Hanisch M; Menne MC
    J Int Med Res; 2024 Apr; 52(4):3000605241242582. PubMed ID: 38603608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature.
    Monaco A; Choi D; Uzun S; Maitland A; Riley B
    Immunol Res; 2022 Aug; 70(4):419-431. PubMed ID: 35449490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests.
    Sobey G
    Arch Dis Child; 2015 Jan; 100(1):57-61. PubMed ID: 24994860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome.
    Afrin LB
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):466-472. PubMed ID: 34719842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on the new classification of Ehlers-Danlos syndrome and review of the causes of bleeding in this population.
    Jesudas R; Chaudhury A; Laukaitis CM
    Haemophilia; 2019 Jul; 25(4):558-566. PubMed ID: 31329366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.